Myeloid-mediated cerebral amyloid vasculitis and the potential role of the immune response in brain atrophy

Dual targeting macrophages and microglia is a therapeutic vulnerability in models of PTEN-deficient glioblastoma

Pediatric glioma immune profiling identifies TIM3 as a therapeutic target in BRAF-Fusion pilocytic astrocytoma

B cell-based therapy produces antibodies that inhibit glioblastoma growth

STING agonist 8803 reprograms the immune microenvironment and increases survival in preclinical models of glioblastoma

Cancer-associated fibroblast–secreted collagen is associated with immune inhibitor receptor LAIR1 in gliomas